How to improve effectiveness of pegvisomant treatment in acromegalic patients

Ragonese, M; Grottoli, S; Maffei, P; Alibrandi, A; Ambrosio, M R; Arnaldi, G; Bianchi, A; Puglisi, S; Zatelli, M C; De Marinis, L; Ghigo, E; Giustina, A; Maffezzoni, F; Martini, C; Trementino, L; Cannavo, S

doi:10.1007/s40618-017-0773-0

Pegvisomant (PEGV) treatment in acromegaly patients resistant to somatostatin analogues is less effective in the real life than in clinical trials. This is a multicenter, observational, retrospective, longitudinal study. The aim was to detect characteristics which improve long-term PEGV effectiveness.

Titolo:	How to improve effectiveness of pegvisomant treatment in acromegalic patients
Autori:	Ragonese, M Grottoli, S Maffei, P Alibrandi, A Ambrosio, M R ARNALDI, Giorgio Bianchi, A (Primo) Puglisi, S Zatelli, M C De Marinis, L Ghigo, E Giustina, A Maffezzoni, F Martini, C TREMENTINO, LAURA Cannavo, S mostra contributor esterni nascondi contributor esterni
Data di pubblicazione:	2018
Rivista:	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Abstract:	Pegvisomant (PEGV) treatment in acromegaly patients resistant to somatostatin analogues is less effective in the real life than in clinical trials. This is a multicenter, observational, retrospective, longitudinal study. The aim was to detect characteristics which improve long-term PEGV effectiveness.
Handle:	http://hdl.handle.net/11566/287189
Appare nelle tipologie:	1.1 Articolo in rivista

File in questo prodotto:

Non ci sono file associati a questo prodotto.

Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/11566/287189

Citazioni

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

CINECA IRIS Institutional Research Information System

File in questo prodotto: